Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$723,443.72
% of Total Estimate Gain
13.65%

Touchstone Strategic Trust-Touchstone Large Company Growth Fund's Neurocrine Biosciences Inc Holding Summary

As of 2025-03-31, Touchstone Strategic Trust-Touchstone Large Company Growth Fund held - shares of Neurocrine Biosciences Inc(NBIX), totaling N/A. This investment constitutes 0% of their stock portfolio, and Touchstone Strategic Trust-Touchstone Large Company Growth Fund now holds 0% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.

The initial trade took place in 2019Q3. And since then Touchstone Strategic Trust-Touchstone Large Company Growth Fund has made 5 purchases of NBIX, at an average price of $99.02, for a total of 53,533.00 shares. In addition, there have been 12 sales at an average price of $112.54 for 53,533.00 shares. Based on historical transaction data and NBIX's current price of $132.75, Touchstone Strategic Trust-Touchstone Large Company Growth Fund's estimated gain on his NBIX holdings is $723,443.72, reflecting a 13.65% gain to date.

Touchstone Strategic Trust-Touchstone Large Company Growth Fund NBIX ($132.75) Holding Chart

Touchstone Strategic Trust-Touchstone Large Company Growth Fund NBIX ($132.75) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1